Design, synthesis and SAR of thienopyridines as potent CHK1 inhibitors

G2 checkpoint abrogators as anticancer drugs

Takumi Kawabe · Molecular Cancer Therapeutics · 2004 · 383 citations · Full text

Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

Edward A. Sausville, Susan G. Arbuck, Richard A. Messmann et al. · Journal of Clinical Oncology · 2001 · 294 citations

Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.

Roderick T. Bunch, Alan Eastman · PubMed · 1996 · 221 citations

Cell Death, Cell Cycle, Cancer Biology +17

Structure-Based Design, Synthesis, and Biological Evaluation of Potent and Selective Macrocyclic Checkpoint Kinase 1 Inhibitors

Zhi‐Fu Tao, Le Wang, Kent D. Stewart et al. · Journal of Medicinal Chemistry · 2007 · 88 citations · Full text

Drug Target, Chemical Biology, Grubbs Metathesis Macrocyclization +18

Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors

Nan‐Horng Lin, Ping Xia, Peter Kovar et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 40 citations · Full text

Medicinal Chemistry, Novel Checkpoint 1, Medicine +8